HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Nestlé Health Science Refocuses As It Drops Peanut Allergy Treatment

Executive Summary

VMS, active nutrition and medical nutrition will be Nestle Health Science's main focus areas going forward with the business looking to offload peanut allergy treatment Palforzia. The Swiss firm announced the move as it reported organic growth of 4% at Health Science for 2022.

You may also be interested in...

People On The Move: Appointments At Nestlé, Sanofi, Fimea

A round-up of the latest appointments in Europe's health and wellness markets: Nestlé Health Science promotes Anna Mohl to CEO; Sanofi Consumer Healthcare names Thomas Bosment Romania country head; Fimea reappoints Eija Pelkonen as director general for another five year term.

Nestlé Invests In Microbiome Research As VMS Sales Stumble

Nestlé announced a partnership with APC Microbiome Ireland for product development as it reported lower vitamin, mineral and supplement sales in the first half of 2023.

Nestlé Insists VMS Market Is Picking Up Despite Lower Sales In Q1

Nestle said a slowdown in the US dietary supplements market was to be expected following a strong increase during the pandemic as it reported lower VMS sales in Q1. “We are starting to see signs of market growth picking up again,” CFO François-Xavier Roger told the Swiss firm’s earnings call.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts